Syphilis Immunoassay Diagnostics Market was valued at $27.55 Billion in 2021 and is projected to reach $42.58 Billion in 2028, growing at a CAGR of 6% from 2022 to 2028. Syphilis is a serious bacterial infection that can affect both men and women. It is also seen in HIV-positive patients. Diagnosis of syphilis should always depend on a […]
Tag Archives: Syphilis Immunoassay Diagnostics Market
The Syphilis Immunoassay Diagnostics Market size is expected to grow at an annual average of 2% during 2021-2027. Syphilis is a chronic bacterial disease spread through sexual intercourse. It can be treated with antibiotics, especially in the early stages. Diagnosis of syphilis should always depend on a high level of clinical suspicion and routine screening […]
Syphilis is a sexually transmitted disease caused by a bacterium called treponema pallidum. Companies in the syphilis immunoassay diagnostics market are innovating in new technologies with the help of dedicated machines to automate rapid plasma regain (RPR) assays. They are improving testing capabilities for laboratories with the help of new software developments to enhance outcomes […]